AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metfos 1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Berlincleve Pharmaceuticals Llp

Salt Composition

Metformin (1000mg)

Overview Metfos 1000mg Tablet SR

Glucovance SR 1000mg tablets are prescribed for managing type 2 diabetes, effectively regulating blood glucose and mitigating associated health risks. This medication also addresses polycystic ovary syndrome (PCOS) in women. For optimal absorption and to minimize gastrointestinal upset, take this extended-release tablet with food, consistently at the same time daily. Discontinue use only under your physician's guidance. Maintaining a healthy lifestyle, including adhering to your doctor's dietary and exercise plan, is crucial for effective diabetes management. Commonly reported side effects include digestive issues (diarrhea, nausea, vomiting, gas, indigestion, abdominal discomfort), weakness, headache, and appetite changes. Hypoglycemia (low blood sugar) is a potential risk, particularly when combined with other diabetes medications, alcohol, or missed meals; regular blood glucose monitoring is essential. Prior to commencing treatment, inform your doctor of any existing kidney, liver, or heart conditions, and if you are pregnant or breastfeeding. Baseline kidney function tests are typically performed before initiating therapy. Limit alcohol consumption to reduce the likelihood of adverse reactions.

Uses of Metfos 1000mg Tablet SR

Managing type 2 diabetes and polycystic ovary syndrome (PCOS)

Major Benefits of Metfos 1000mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metfos 1000mg Tablet SR should be administered with a meal.

Common Side effects of Metfos 1000mg Tablet SR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Metfos 1000mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metfos 1000mg Tablet SR whole; avoid chewing, crushing, or breaking it. Consume this extended-release tablet with a meal.

How Metfos 1000mg Tablet SR works:

Metformin 1000mg extended-release tablets are a biguanide-class antidiabetic drug. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Metfos 1000mg Tablet SR is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

Extended-release Metformin 1000mg tablets are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingCAUTION

Extended-release metformin 1000mg tablets require careful consideration during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metfos 1000mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is essential. Metfos 1000mg SR tablets are contraindicated in individuals with severe kidney disease.

LiverLiverUNSAFE

Extended-release metformin 1000mg tablets are contraindicated in individuals with hepatic impairment and should be omitted. Seek medical advice.

What if you forget to take Metfos 1000mg Tablet SR :

Should you forget a Metfos 1000mg Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metfos 1000mg Tablet SR

LabelValue
Pharmacological Category Biguanide-based medication
Potential for Dependence None.
Medication Category Medication for diabetes

FAQs on Metfos 1000mg Tablet SR

Individuals with type 2 diabetes exhibit impaired responsiveness to their body's own insulin. Consequently, blood glucose levels rise. Metfos 1000mg Tablet SR employs multiple mechanisms to lower elevated blood sugar. This medication reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in tissues. These actions facilitate improved glucose uptake from the bloodstream and optimize the body's natural insulin response.
Metformin 1000mg extended-release tablets have demonstrated weight reduction benefits in overweight and obese patients. This effect may also be observed in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin resistance or sensitivity may experience weight loss. However, self-prescribing Metformin for weight management is strongly discouraged; always seek medical advice before initiating treatment.
Extended-release Metformin 1000mg tablets are frequently a first-line treatment for hyperglycemia. This medication manages blood glucose by enhancing insulin sensitivity, reducing hepatic glucose production, and diminishing intestinal glucose absorption. Differing from other oral hypoglycemics, Metformin 1000mg SR, when used monotherapy, infrequently leads to hypoglycemia due to its mechanism that avoids excessive pancreatic insulin release. Beyond glycemic control, it also aids in weight management.
Metfos 1000mg extended-release tablets generally do not induce drowsiness and are typically well-tolerated. Infrequently, however, Metfos 1000mg extended-release tablets may result in sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially in individuals with impaired renal function. Seek medical attention if fatigue or sleepiness develops during Metfos 1000mg extended-release tablet use.
Administer Metfos 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, consume in the morning with breakfast. Twice-daily regimens should involve one tablet with breakfast and one with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metfos 1000mg SR with food mitigates potential gastrointestinal distress, such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their endogenous insulin. This leads to elevated blood glucose concentrations. Metfos 1000mg Tablet SR employs multiple mechanisms to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in muscles and other organs. This combined action facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Metformin 1000mg extended-release tablets have demonstrated weight reduction benefits in overweight or obese individuals. This weight loss effect may also be observed, albeit modestly, in overweight or obese patients predisposed to diabetes. Furthermore, individuals with insulin resistance or sensitivity may experience similar results. However, self-initiation of this medication for weight management is inadvisable; physician consultation is essential.
Extended-release Metformin 1000mg tablets are frequently a first-line treatment for hyperglycemia. This medication manages blood glucose by enhancing insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, monotherapy with Metformin 1000mg extended-release tablets seldom results in hypoglycemia due to its mechanism that avoids excessive pancreatic insulin release. Beyond glycemic control, it also aids in weight management.
Metfos 1000mg extended-release tablets generally do not induce drowsiness and are well-received. Infrequently, however, Metfos 1000mg extended-release tablets may lead to sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Metfos 1000mg extended-release tablet treatment.
Administer Metfos 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, consume with breakfast. Twice-daily prescriptions should be divided, one with breakfast and one with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metfos 1000mg SR with food mitigates gastrointestinal distress such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals diagnosed with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to endogenous insulin. This deficiency leads to elevated blood glucose concentrations. Metfos 1000mg Tablet SR counteracts hyperglycemia through multiple mechanisms. It reduces hepatic glucose output, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in peripheral tissues. These actions facilitate improved glucose uptake from the bloodstream and optimize the body's natural insulin utilization.
Metformin 1000mg extended-release tablets have demonstrated weight reduction benefits in overweight and obese patients. This weight loss effect may also be observed in overweight and obese individuals predisposed to diabetes. Furthermore, individuals with insulin resistance or sensitivity may experience weight loss. However, self-medicating with this drug for weight management is strongly discouraged; physician consultation is essential.
Extended-release Metformin 1000mg tablets are frequently a first-line treatment for elevated blood glucose. This medication manages blood sugar by enhancing the body's insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, Metformin 1000mg SR tablets, when used monotherapy, infrequently lead to hypoglycemia due to their mechanism of action which avoids excessive pancreatic insulin release. Beyond glycemic control, this medication also aids in weight management.
Metfos 1000mg Extended-Release tablets generally do not induce drowsiness and are well-received. Infrequently, though, Metfos 1000mg Extended-Release tablets can lead to sleep disturbances and insomnia. Somnolence may signal a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Metfos 1000mg Extended-Release tablet use.
Administer Metfos 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, take the tablet in the morning with breakfast. If two tablets are prescribed, take one with breakfast and one with dinner. For three daily doses, distribute them with breakfast, lunch, and dinner. Consuming Metfos 1000mg SR with food mitigates potential gastrointestinal distress such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Metfos 1000mg Tablet SR
28
MRP 33
15% off